Real-world experience with idarucizumab for dabigatran reversal in a third-level hospital

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-052
• By: DOMINGUEZ BRAHONA, Ana (Hospital Virgen de la Salud, Pharmacy)
• Co-author(s): Ana Dominguez Barahona
  Cristina Blázquez Romero
  Helena Quirós Ambel
  Ana García Sacristán
  Silvia Gonzalez Suarez
  Ana Rosa Rubio Salvador
  Nuria Labrador Andújar
  Paloma Moya Gomez
  
• Abstract:

  Background

  Idarucizumab has been approved for use when reversal of the anticoagulant effects of dabigatran is needed for urgent procedures or in patients with life-threatening bleeding.

  Methods

  Observational, descriptive, retrospective (April 2017-April 2018) and longitudinal study of patients treated with idarucizumab in a general hospital of 650
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login